BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11583714)

  • 1. TCV-116 stimulates eNOS and caveolin-1 expression and improves coronary microvascular remodeling in normotensive and angiotensin II-induced hypertensive rats.
    Kobayashi N; Mori Y; Nakano S; Tsubokou Y; Kobayashi T; Shirataki H; Matsuoka H
    Atherosclerosis; 2001 Oct; 158(2):359-68. PubMed ID: 11583714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of angiotensin II type 1 receptor antagonist on nitric oxide synthase expression and myocardial remodeling in Goldblatt hypertensive rats.
    Higashi T; Kobayashi N; Hara K; Shirataki H; Matsuoka H
    J Cardiovasc Pharmacol; 2000 Apr; 35(4):564-71. PubMed ID: 10774787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of TCV-116 on endothelin-1 and PDGF A-chain expression in angiotensin II-induced hypertensive rats.
    Hara K; Kobayashi N; Nakano S; Mori Y; Tsubokou Y; Matsuoka H
    Hypertens Res; 2001 Jan; 24(1):55-64. PubMed ID: 11213031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
    Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
    Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of TCV-116 on expression of NOS and adrenomedullin in failing heart of Dahl salt-sensitive rats.
    Kobayashi N; Nishikimi T; Horinaka S; Ishimitsu T; Matsuoka H
    Atherosclerosis; 2001 Jun; 156(2):255-65. PubMed ID: 11395021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
    Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
    Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism.
    Brilla CG; Scheer C; Rupp H
    J Hypertens Suppl; 1997 Dec; 15(6):S13-9. PubMed ID: 9493122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celiprolol stimulates endothelial nitric oxide synthase expression and improves myocardial remodeling in deoxycorticosterone acetate-salt hypertensive rats.
    Kobayashi N; Mori Y; Nakano S; Tsubokou Y; Shirataki H; Matsuoka H
    J Hypertens; 2001 Apr; 19(4):795-801. PubMed ID: 11330883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
    Takeda K; Fujita H; Nakamura K; Uchida A; Tanaka M; Itoh H; Nakata T; Sasaki S; Nakagawa M
    Blood Press Suppl; 1994; 5():94-8. PubMed ID: 7889211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of Rho-kinase pathway for angiotensin II-induced plasminogen activator inhibitor-1 gene expression and cardiovascular remodeling in hypertensive rats.
    Kobayashi N; Nakano S; Mita S; Kobayashi T; Honda T; Tsubokou Y; Matsuoka H
    J Pharmacol Exp Ther; 2002 May; 301(2):459-66. PubMed ID: 11961044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats.
    Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Ishimura Y; Chatani F; Iwao H
    J Pharmacol Exp Ther; 1995 Apr; 273(1):509-15. PubMed ID: 7714806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of imidapril on NOS expression and myocardial remodelling in failing heart of Dahl salt-sensitive hypertensive rats.
    Kobayashi N; Higashi T; Hara K; Shirataki H; Matsuoka H
    Cardiovasc Res; 1999 Dec; 44(3):518-26. PubMed ID: 10690283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCV-116, a newly developed angiotensin II receptor antagonist, induces regression of cardiac hypertrophy through suppression of the tissue renin-angiotensin system in spontaneously hypertensive rats.
    Mizuno K; Niimura S; Katoh K; Fukuchi S
    Life Sci; 1994; 54(25):1987-94. PubMed ID: 8201847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of imidapril on myocardial remodeling in L-NAME-induced hypertensive rats is associated with gene expression of NOS and ACE mRNA.
    Kobayashi N; Hara K; Watanabe S; Higashi T; Matsuoka H
    Am J Hypertens; 2000 Feb; 13(2):199-207. PubMed ID: 10701821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition.
    Yamakawa H; Jezova M; Ando H; Saavedra JM
    J Cereb Blood Flow Metab; 2003 Mar; 23(3):371-80. PubMed ID: 12621312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury.
    Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
    Kidney Int; 1994 Nov; 46(5):1346-58. PubMed ID: 7853793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benidipine stimulates nitric oxide synthase and improves coronary circulation in hypertensive rats.
    Kobayashi N; Kobayashi K; Hara K; Higashi T; Yanaka H; Yagi S; Matsuoka H
    Am J Hypertens; 1999 May; 12(5):483-91. PubMed ID: 10342786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normalizing the expression of nitric oxide synthase by low-dose AT1 receptor antagonism parallels improved vascular morphology in hypertensive rats.
    Bennai F; Morsing P; Paliege A; Ketteler M; Mayer B; Tapp R; Bachmann S
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S104-15. PubMed ID: 9892150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction.
    Hanatani A; Yoshiyama M; Kim S; Omura T; Toda I; Akioka K; Teragaki M; Takeuchi K; Iwao H; Takeda T
    J Mol Cell Cardiol; 1995 Sep; 27(9):1905-14. PubMed ID: 8523451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cilnidipine on nitric oxide and endothelin-1 expression and extracellular signal-regulated kinase in hypertensive rats.
    Kobayashi N; Mori Y; Mita S; Nakano S; Kobayashi T; Tsubokou Y; Matsuoka H
    Eur J Pharmacol; 2001 Jun; 422(1-3):149-57. PubMed ID: 11430925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.